Biography

Dr. Kolonin is an Associate Professor and Director of the Center for Metabolic and Degenerative Diseases at the University of Texas in Houston. As a PhD from Wayne State University, he pioneered the concept of expressing peptides disrupting protein interactions in animals. As a post-doctoral fellow at M.D. Anderson Cancer Center, he screened combinatorial libraries to identify druggable cell surface markers. Based on this approach, Dr. Kolonin has invented experimental therapeutics for obesity and cancer. Dr. Kolonin is an author of over 60 publications, and has editorial positions with Molecular Carcinogenesis and Cancer Research. Dr. Kolonin is endowed with a Distinguished University Chair in Metabolic Disease Research.

---

Research Interest

Current research in the Kolonin Laboratory converges on stem cells, obesity, and cancer. His studies, based on the analysis of clinical specimens and mouse models, focus is on the role of fat tissue cells in pathology.